Search Results - "Zhang, Chaoting"

Refine Results
  1. 1

    Characterization of Microbiota in Cancerous Lung and the Contralateral Non-Cancerous Lung Within Lung Cancer Patients by Zhuo, Minglei, An, Tongtong, Zhang, Chaoting, Wang, Ziping

    Published in Frontiers in oncology (24-08-2020)
    “…The functional role of lung microbiota has attracted an accumulating attention recently, but the profile and functional role of the lung microbiota in patients…”
    Get full text
    Journal Article
  2. 2

    Membrane-bound IL-7 immobilized by the CD8 transmembrane region improves efficacy of CD19 CAR-T cell therapy by Zhang, Chaoting, Liu, Ting, Li, Shance, Teng, Xia, Zhu, Yuge, Zhang, Guanyu, Xie, Huimin, Sun, Kang, Tu, Jiaxin, Yang, Wenjun, Lu, Zheming

    Published in Molecular cancer (23-10-2024)
    “…Enhancing the efficacy of CD19 CAR-T cell therapy can significantly improve patient outcomes by reducing relapse rates in CD19 + B cell malignancies. Exogenous…”
    Get full text
    Journal Article
  3. 3

    CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies by Liang, Yun, Liu, Hui, Lu, Zheming, Lei, Wen, Zhang, Chaoting, Li, Ping, Liang, Aibin, Young, Ken H, Qian, Wenbin

    Published in Journal of hematology and oncology (16-02-2021)
    “…CD19-targeted chimeric antigen receptor T (CAR T) cell therapy is a promising option to treat relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)…”
    Get full text
    Journal Article
  4. 4

    Pre-depletion of TRBC1+ T cells promotes the therapeutic efficacy of anti-TRBC1 CAR-T for T-cell malignancies by Zhang, Chaoting, Palashati, Heyilimu, Rong, Zhuona, Lin, Ningjing, Shen, Luyan, Liu, Ying, Li, Shance, Yu, Bentong, Yang, Wenjun, Lu, Zheming

    Published in Molecular cancer (21-11-2020)
    “…Abstract Targeting T cell receptor β-chain constant region 1 (TRBC1) CAR-T could specifically kill TRBC1+ T-cell malignancies. However, over-expressed CARs on…”
    Get full text
    Journal Article
  5. 5

    Clonal Distribution and Intratumor Heterogeneity of the TCR Repertoire in Papillary Thyroid Cancer With or Without Coexistent Hashimoto’s Thyroiditis by Cui, Likun, Zhang, Chaoting, Ding, Huirong, Feng, Dongdong, Huang, Hongying, Lu, Zheming, Liu, Baoguo

    Published in Frontiers in immunology (03-06-2022)
    “…The intratumor heterogeneity (ITH) of the amount and TCR repertoires of tumor infiltrating lymphocytes (TILs) in PTC with and without coexistent Hashimoto’s…”
    Get full text
    Journal Article
  6. 6

    The direct and indirect association of cervical microbiota with the risk of cervical intraepithelial neoplasia by Zhang, Chaoting, Liu, Ying, Gao, Weijiao, Pan, Yaqi, Gao, Yunong, Shen, Jing, Xiong, Hongchao

    Published in Cancer medicine (Malden, MA) (01-05-2018)
    “…Cervical microbiota composition is associated with cervical HPV infection and CIN severity. Previous studies only assessed the total association between…”
    Get full text
    Journal Article
  7. 7

    T cell receptor β‐chain repertoire analysis of tumor‐infiltrating lymphocytes in pancreatic cancer by Cui, Can, Tian, Xiuyun, Wu, Jianhui, Zhang, Chaoting, Tan, Qin, Guan, Xiaoya, Dong, Bin, Zhao, Min, Lu, Zheming, Hao, Chunyi

    Published in Cancer science (01-01-2019)
    “…Pancreatic cancer is lethal due to lack of perceptible symptoms and effective treatment methods. Immunotherapy may provide promising therapeutic choices for…”
    Get full text
    Journal Article
  8. 8

    Pharmacologic inhibition of IL11/STAT3 signaling increases MHC-I expression and T cell infiltration by Xiong, Wenjun, Chen, Yuehong, Zhang, Chaoting, Li, Jin, Huang, Haipeng, Zhu, Yu, Deng, Guangxu, Cheng, Junhong, Lin, Yixiong, Shi, Zhimin, Mou, Tingyu

    Published in Journal of translational medicine (26-06-2023)
    “…Recent studies have discovered an emerging role of IL11 in various colitis-associated cancers, suggesting that IL11 mainly promotes tumor cell survival and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignancies by Zhang, Chaoting, Tan, Qin, Li, Shance, Shen, Luyan, Zhang, Jingtao, Liu, Ying, Yang, Wenjun, Lu, Zheming

    Published in Journal for immunotherapy of cancer (01-07-2021)
    “…BackgroundLatent membrane protein-2A (LMP2A)-specific TCR-engineered T cells could be a promising treatment approach to Epstein–Barr virus-associated…”
    Get full text
    Journal Article
  11. 11

    Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes by Zhang, Chaoting, Sun, Yizhe, Li, Shance, Shen, Luyan, Teng, Xia, Xiao, Yefei, Wu, Nan, Lu, Zheming

    Published in Journal for immunotherapy of cancer (01-10-2022)
    “…BackgroundAlthough adoptive cell therapy with tumor infiltrating lymphocytes (TILs) has mediated effective antitumor responses in several cancers, dysfunction…”
    Get full text
    Journal Article
  12. 12

    Seroprevalence of Merkel cell polyomavirus in the general rural population of Anyang, China by Zhang, Chanyuan, Liu, Fangfang, He, Zhonghu, Deng, Qiuju, Pan, Yaqi, Liu, Ying, Zhang, Chaoting, Ning, Tao, Guo, Chuanhai, Liang, Yongmei, Xu, Ruiping, Zhang, Lixin, Cai, Hong, Ke, Yang

    Published in PloS one (2014)
    “…Despite the probably causal link between Merkel cell polyomavirus (MCPyV) infection and Merkel cell carcinoma (MCC), a rare but aggressive skin malignancy,…”
    Get full text
    Journal Article
  13. 13

    Epidemiology of self-rated health in rural China: a population-based cross-sectional study by Liu, Fangfang, Zhang, Chaoting, Liang, Yongmei, Deng, Qiuju, Hang, Dong, Pan, Yaqi, Li, Xiang, He, Zhonghu, Liu, Mengfei, Liu, Ying, Li, Jingjing, Ning, Tao, Guo, Chuanhai, Xu, Ruiping, Zhang, Lixin, Cai, Hong, Ke, Yang

    Published in Scientific reports (30-06-2017)
    “…Self-rated health (SRH) has been shown to be a good predictor of mortality. Data on SRH and its associated factors in the Chinese general population are…”
    Get full text
    Journal Article
  14. 14

    Autophagic flux restoration of senescent T cells improves antitumor activity of TCR‐engineered T cells by Zhang, Chaoting, Sun, Yizhe, Li, Shance, Shen, Luyan, Teng, Xia, Xiao, Yefei, Zhou, Ping, Lu, Zheming

    “…Objectives Although adoptive cell therapy with T‐cell receptor‐engineered T cells (TCR‐Ts) has mediated effective antitumor responses in several cancers,…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Concurrence of oral and genital human papillomavirus infection in healthy men: a population-based cross-sectional study in rural China by Liu, Fangfang, Hang, Dong, Deng, Qiuju, Liu, Mengfei, Xi, Longfu, He, Zhonghu, Zhang, Chaoting, Sun, Min, Liu, Ying, Li, Jingjing, Pan, Yaqi, Ning, Tao, Guo, Chuanhai, Liang, Yongmei, Xu, Ruiping, Zhang, Lixin, Cai, Hong, Ke, Yang

    Published in Scientific reports (27-10-2015)
    “…Human papillomavirus (HPV) infection, a primary cause of genital cancer, is also related to the increasing incidence of oropharyngeal cancer among young men…”
    Get full text
    Journal Article
  17. 17

    Differential DNA methylation profiles of human B lymphocytes and Epstein-Barr virus-immortalized B lymphocytes by Zhang, Chaoting, Zhang, Rui, Chen, Zhiqiang, Chen, Jing, Ruan, Jigang, Lu, Zheming, Xiong, Hongchao, Yang, Wenjun

    Published in Chinese journal of cancer research (01-02-2018)
    “…This study aimed to comprehensively assess Epstein-Barr virus (EBV)-induced methylation alterations of B cell across whole genome. We compared DNA methylation…”
    Get full text
    Journal Article
  18. 18

    CD19-specific CAR T Cells that Express a PD-1/CD28 Chimeric Switch-Receptor are Effective in Patients with PD-L1-positive B-Cell Lymphoma by Liu, Hui, Lei, Wen, Zhang, Chaoting, Yang, Chunmei, Wei, Juying, Guo, Qunyi, Guo, Xiaojun, Chen, Zhilu, Lu, Ying, Young, Ken H, Lu, Zheming, Qian, Wenbin

    Published in Clinical cancer research (15-01-2021)
    “…CD19-specific chimeric antigen receptor (CAR) T-cell therapy is effective against refractory or relapsed (R/R) B-cell lymphoma, but the efficacy is hindered by…”
    Get full text
    Journal Article
  19. 19

    Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activity by Shen, Luyan, Xiao, Yefei, Zhang, Chaoting, Li, Shance, Teng, Xia, Cui, Likun, Liu, Ting, Wu, Nan, Lu, Zheming

    Published in Cancer letters (10-07-2022)
    “…The inadequate in vivo persistence of chimeric antigen receptor (CAR)-modified T cells has been shown to lead to poor therapeutic efficacy and disease…”
    Get full text
    Journal Article
  20. 20

    TCR repertoire intratumor heterogeneity of CD4+ and CD8+ T cells in centers and margins of localized lung adenocarcinomas by Zhang, Chaoting, Ding, Huirong, Huang, Hongying, Palashati, Heyilimu, Miao, Yu, Xiong, Hongchao, Lu, Zheming

    Published in International journal of cancer (15-02-2019)
    “…Intratumor heterogeneity (ITH) of T cell receptor (TCR) repertoire in different T‐cell subsets and locations in lung adenocarcinomas was unclear. Here, we…”
    Get full text
    Journal Article